Riluzole in ASD Study
Children and adolescents with autism spectrum disorder (ASD) sometimes have a difficult time talking to other children, or making friends. However, there are currently no medications available for these problems or for the repetitive behaviours persons with ASD experience.
The study looked at a medication called Riluzole as a possible treatment for the core symptoms of ASD. Riluzole is currently used to treat a neurological disorder in adults. During the study, researchers explored whether or not there was evidence that the medication worked, and if it had been safe and effective in children and young people, aged 6 to 17 years.
One of the aims of the study had been to recruit 60 children from Holland Bloorview Kids Rehabilitation Hospital, Lawson Health Research Institute, and McMaster University to take part in this study.
This study is no longer recruiting participants.